Back to top
more

Quest Diagnostics (DGX)

(Delayed Data from NYSE)

$155.29 USD

155.29
1,094,683

+0.46 (0.30%)

Updated Nov 1, 2024 04:00 PM ET

After-Market: $155.34 +0.05 (0.03%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value F Growth F Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 12% (29 out of 250)

Industry: Medical - Outpatient and Home Healthcare

Better trading starts here.

Zacks News

Quest Diagnostics New Tests Uptake Strong Amid Coronavirus Woe

Heavy demand for COVID-19 molecular testing helps partially offset the base volume decline for Quest Diagnostics (DGX).

Has Quest Diagnostics (DGX) Outpaced Other Medical Stocks This Year?

Is (DGX) Outperforming Other Medical Stocks This Year?

The Zacks Analyst Blog Highlights: MDRX, VEEV, DGX, TMO and ZM

The Zacks Analyst Blog Highlights: MDRX, VEEV, DGX, TMO and ZM

Urmimala Biswas headshot

Is Another Great Depression Imminent or Is it Just a Myth?

Asian countries have already shown clear signs of major economic recession.

Thermo Fisher Expands Lab Plastic Making for Coronavirus Support

Thermo Fisher (TMO) consumables already support critical COVID-19 work and include sample collection vials and lab essentials.

Quest Diagnostics (DGX) Outpaces Stock Market Gains: What You Should Know

Quest Diagnostics (DGX) closed the most recent trading day at $113.59, moving +0.77% from the previous trading session.

The Zacks Analyst Blog Highlights: Quest Diagnostics, Abbott, Quidel, QIAGEN and Thermo Fisher Scientific

The Zacks Analyst Blog Highlights: Quest Diagnostics, Abbott, Quidel, QIAGEN and Thermo Fisher Scientific

Urmimala Biswas headshot

3 Med Info Stocks to Improve Portfolio Health Amid Coronavirus Woes

Postponement of elective surgeries leading to lower product bookings cloud Zacks-Medical Info Systems industry prospects. However, coronavirus-led demand for contactless services should aid the space. TXG, MDRX, NXGN should be the forerunners.

Urmimala Biswas headshot

Coronavirus Test Makers With Scope to Maximize Investor Benefits

The surge in new coronavirus infections broadens the scope for antigen and antibody tests.

Quest Diagnostics (DGX) Stock Sinks As Market Gains: What You Should Know

Quest Diagnostics (DGX) closed at $107.05 in the latest trading session, marking a -0.33% move from the prior day.

Quest Diagnostics (DGX) Gains But Lags Market: What You Should Know

Quest Diagnostics (DGX) closed the most recent trading day at $110.69, moving +0.95% from the previous trading session.

Trina Mukherjee headshot

3 Top Outpatient and Home Healthcare Stocks to Watch Out For

Despite the challenges thrown by the COVID-19 pandemic, rising dependence on telehealth and AI's dominant role should drive the Zacks Medical - Outpatient and Home Healthcare industry. DVA, USPH and PNTG are well positioned to gain from the prospects.

The Zacks Analyst Blog Highlights: Abbott Lab, Quidel, Becton, Dickinson and Company, Hologic and Quest Diagnostics

The Zacks Analyst Blog Highlights: Abbott Lab, Quidel, Becton, Dickinson and Company, Hologic and Quest Diagnostics

Urmimala Biswas headshot

Price War in Coronavirus Test Space to Intensify Thanks to Abbott

Most rapid antigen tests in the United States require an additional system, which is making the procedures more costly and complex.

Why Is Quest Diagnostics (DGX) Down 7.7% Since Last Earnings Report?

Quest Diagnostics (DGX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Anthem, Quest Tie up to Improve Healthcare Across the US

Anthem (ANTM) teams up with Quest in order to improve health outcomes to consumers with the help of their innovative solutions.

Is Quest Diagnostics (DGX) a Great Value Stock Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks.com featured highlights include: Quest Diagnostics, eBay, Cisco Systems, Cigna and AbbVie

Zacks.com featured highlights include: Quest Diagnostics, eBay, Cisco Systems, Cigna and AbbVie

Urmimala Biswas headshot

5 Coronavirus-Proof GARP Stocks to Pick on Discounted PEG

A lower PEG ratio, preferably less than 1, is always better for GARP investors.

Here's Why You Should Add AMN Healthcare to Your Portfolio

Investor confidence is high in AMN Healthcare (AMN) stock, thanks to solid prospects.

Quest Diagnostics' (DGX) Q2 Earnings Beat, Volume Declines

Following the guidance withdrawal last quarter, Quest Diagnostics (DGX) provides its full-year projection alongside Q2 earnings release.

Quest Diagnostics (DGX) Surpasses Q2 Earnings and Revenue Estimates

Quest Diagnostics (DGX) delivered earnings and revenue surprises of 0.71% and 0.16%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Has Quest Diagnostics (DGX) Outpaced Other Medical Stocks This Year?

Is (DGX) Outperforming Other Medical Stocks This Year?

Here's Why You Should Add QIAGEN (QGEN) to Your Portfolio

Investors continue to be optimistic about QIAGEN (QGEN) on robust segmental and geographical growth.

Why Earnings Season Could Be Great for Quest Diagnostics (DGX)

Quest Diagnostics (DGX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.